Search by Drug Name or NDC
NDC 50090-4188-00 Oseltamivir Phosphate 6 mg/mL Details
Oseltamivir Phosphate 6 mg/mL
Oseltamivir Phosphate is a ORAL POWDER, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is OSELTAMIVIR PHOSPHATE.
MedlinePlus Drug Summary
Oseltamivir is used to treat some types of influenza infection ('flu') in adults, children, and infants (older than 2 weeks of age) who have had symptoms of the flu for no longer than 2 days. This medication is also used to prevent some types of flu in adults and children (older than 1 year of age) when they have spent time with someone who has the flu or when there is a flu outbreak. Oseltamivir is in a class of medications called neuraminidase inhibitors. It works by stopping the spread of the flu virus in the body. Oseltamivir helps shorten the time that flu symptoms such as a stuffy or runny nose, sore throat, cough, muscle or joint aches, tiredness, headache, fever, and chills last. Oseltamivir will not prevent bacterial infections, which may occur as a complication of the flu.
Related Packages: 50090-4188-00Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Oseltamivir
Product Information
| NDC | 50090-4188 |
|---|---|
| Product ID | 50090-4188_18da07a0-8914-4e1a-9196-1ac023659e3d |
| Associated GPIs | 12504060201910 |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Oseltamivir Phosphate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Oseltamivir Phosphate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | POWDER, FOR SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 6 |
| Active Ingredient Units | mg/mL |
| Substance Name | OSELTAMIVIR PHOSPHATE |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA208347 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-4188-00 (50090418800)
| NDC Package Code | 50090-4188-0 |
|---|---|
| Billing NDC | 50090418800 |
| Package | 1 BOTTLE, GLASS in 1 CARTON (50090-4188-0) / 60 mL in 1 BOTTLE, GLASS |
| Marketing Start Date | 2019-03-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |